R&D Systems™ Recombinant Human TACE/ADAM17 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity

The Recombinant Human TACE/ADAM17 Protein is derived from Sf 21 (baculovirus). The Recombinant Human TACE/ADAM17 Protein has been validated for the following applications: Enzyme Activity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in Tris, NaCl and Brij-35.
• Gene ID (Entrez): 6868
• Molecular Weight (g/mol): 52 kDa
• Name: TACE/ADAM17
• Quantity: 10 μg
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human TACE/ADAM17 protein Arg215-Asn671,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Mature form. Recombinant Human TACE/ADAM17 is prone to proteolytic cleavage at C-terminus. The predominant form of the purified protein lacks the His tag.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.